Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Bayer Has No End in Sight for Roundup Non-Hodgkins Lymphoma Lawsuits After Supreme Court Refuses to Consider Appeal U.S. Supreme Court rejected an appeal Bayer hoped would end the ability for thousands of Roundup lawsuits to move forward over allegations that non-Hodgkin’s lymphoma was caused by the weed killer June 21, 2022 Irvin Jackson Add Your Comments The U.S. Supreme Court has decided not to even consider a request filed by Bayer to overturn a $25 million verdict awarded to a man who developed non-Hodgkin’s lymphoma from Roundup, which raised allegations similar to those in thousands of lawsuits being pursued by former users of the ubiquitous glyphosate-based weed killer. At one point Bayer and it’s Monsanto subsidiary faced nearly 100,000 Roundup non-Hodgkin’s lymphoma lawsuits, alleging that information and warnings about the cancer risk associated with the weed killer was withheld from consumers and regulators for years. Following a series of massive jury awards returned in favor of plaintiffs in 2018 and 2019, Bayer agreed to pay billions in Roundup settlements. However, it has continued to pursue appeals from several early verdicts, and thousands of claims continue to work their way through the court system after plaintiffs rejected offers to settle. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Although it is rare for the U.S. Supreme Court to grant review of a civil verdict, only agreeing to consider less than 1% of all claims presented, Bayer has rested much of its legal defense strategy on convincing the U.S. Supreme Court to dismiss the remaining litigation, arguing that the claims should be pre-empted since the EPA authorized the glyphosate-based weed killer. Bayer told investors last year that if it was successful on appeal with the Supreme Court, it could “effectively end future litigation” over Roundup. However, those hopes appear to have been dashed. Yesterday, the Supreme Court Justices indicated that they will not even consider a petition filed by Bayer, leaving intact a judgement awarded to Edwin Hardeman, which was the first case to go before a federal jury. The Supreme Court gave no opinion on why it rejected Bayer’s appeal, but the decision comes after the U.S. Solicitor General urged the Court not to consider the case. Hardeman developed non-Hodgkin’s lymphoma after spraying Roundup around his home for decades. In March 2019, a federal jury in California ordered Bayer to pay $80 million, which was later reduced down to $25 million by the Ninth Circuit Court of Appeals. However, the liability finding was kept intact. Bayer filed a petition for a Supreme Court Roundup appeal in the case in August 2021, arguing that since Roundup’s warning label was approved by the U.S. Environmental Protection Agency (EPA), the company should be shielded from failure to warn claims brought by Hardeman and others, who claim the label warnings were insufficient. It is also challenging some of the expert witness testimony used by Hardeman’s legal team during the trial. On May 10, U.S. Solicitor General Elizabeth B. Prelogar, filed an amicus brief with the Supreme Court, urging the high court to reject Bayer’s petition. She argued that the Court of Appeals found California common law paralleled federal laws which prohibit products from being misbranded, and that the Supreme Court should affirm the Ninth Circuit’s rejection of Bayer’s claim that EPA’s decision to allow Roundup to go on shelves without a cancer warning prevents California from requiring one. California, the EPA and Bayer and Monsanto have battled for years over whether Roundup should be listed on California’s Prop 65 toxic chemicals list. Various judges have bounced back and forth on the issue, with a federal judge issuing a permanent injunction in 2020 preventing the state from forcing Roundup products to carry cancer label warnings. With no opinion given, it is unclear which arguments were persuasive to the Court. Bayer has also petitioned the Supreme Court to overturn a verdict in a second case, which led to an $87 million verdict for Alva and Alberta Pilliod, a California couple who both say they developed cancer after years of Roundup use. However, the recent decision to rejection the petition in the Hardeman seems to make it unlikely the Supreme Court will grant a review in the Pilliod matter. Tags: Bayer, Glyphosate, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Supreme Court, Weed Killer More Roundup Lawsuit Stories Georgia Lawmakers Agree To Shield Bayer From Roundup Cancer Lawsuits May 15, 2025 Roundup Exposure May Increase Infertility, Endometriosis Risks: Study May 1, 2025 Bayer Appeals Roundup Lawsuits to U.S. Supreme Court Again April 7, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)